When was EnginZyme founded?

EnginZyme was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is EnginZyme located?

EnginZyme is headquartered in Stockholm, Sweden.

How many employees does EnginZyme have?

As of Aug 31, 2026, the latest employee count at EnginZyme is 36.

Is EnginZyme a funded company?

EnginZyme is a funded company, having raised a total of $42.3M across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2020.

When was the latest funding round of EnginZyme?

EnginZyme's latest funding was a $***** Series B round on Sep 24, 2026, with participation from 6 investors.

Where does EnginZyme rank among its competitors?

EnginZyme ranks 4th amongst 92 active competitors, of which 16 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Immobazyme, which secured $1.5M in Dec, 2025.

Who are the top competitors of EnginZyme?

EnginZyme's top competitors include Codexis, Debut and CellRev. Among them, EnginZyme secured the most recent funding round in September, 2026.

EnginZyme - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of immobilized enzymes. It employs a patented enzyme immobilization technology that enables the use of enzymes as catalysts in chemical processes. Its core technology allows for productive enzyme usage in various applications, including food, cosmetics, and pharmaceuticals.

Website: enginzyme.com
Social
Email ID: *****@enginzyme.com
Phone Number: +46 **********

Key Metrics

Founded Year

2014

Location

Stockholm, Sweden

Stage

Series B

Total Funding

$42.3M in 5 rounds

Latest Funding Round

Series B, Sep 24, 2026, $*****

Investors

Bunge & 6 more

Ranked

4^th among 92 active competitors

Employee Count

36 as on Aug 31, 2026

Similar Companies

Codexis & 104 more

View EnginZyme's full profile

EnginZyme is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Enginzyme Ab CIN: 556965-8494 , Sweden, Active	Mar 18, 2014	-	-	-

EnginZyme has raised a total funding of $42.3M over 5 rounds. Its first funding round was on Jan 01, 2020. Its latest funding round was a Series B round on Sep 24, 2026 for $*****. 6 investors participated in its latest round. EnginZyme has 7 institutional investors.

Here is the list of recent funding rounds of EnginZyme:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 24, 2026	2041939	Series B	7333804	2707345	1825076	2011336
Dec 19, 2022	4293103	Series B	6173879	3204111	6383517	Sofinnova Partners & 2 more
Feb 11, 2021	5826425	Series A	3617082	6324856	Industrifonden	SEB

Access funding benchmarks and valuations. Sign up today!

View details of EnginZyme's funding rounds and investors

The founders of EnginZyme are Robin Chatterjee, Samuel Hargestam and Karim Engelmark Cassimjee.

Here are the details of EnginZyme's key team members:

Robin Chatterjee: Co-Founder of EnginZyme.
Samuel Hargestam: Co-Founder of EnginZyme.
Karim Engelmark Cassimjee: Co-Founder & CIO of EnginZyme.
Contact Info: 1 email address

View details of EnginZyme's Founder profiles and Board Members

EnginZyme's employee count trend

EnginZyme has 36 employees as of Aug 26. Here is EnginZyme's employee count trend over the years:

Uncover EnginZyme's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EnginZyme include Codexis, Debut and CellRev. Here is the list of Top 10 competitors of EnginZyme, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Codexis 2002, Redwood City (United States), Public	Developer of high-performance enzymes for drug discovery	$111M	EDBI, Casdin Capital & 12 others	68/100
2nd	Debut 2019, San Diego (United States), Series B	Provider and manufacturer of enzymes for biotherapeutic creation and modification	$126M	BOLD, Material Impact & 16 others	62/100
3rd	CellRev 2019, Newcastle Upon Tyne (United Kingdom), Series A	Developer of cell cultivation technologies	$19.6M	CPT Capital, Happiness Capital & 10 others	61/100
4th	EnginZyme 2014, Stockholm (Sweden), Series B	Developer of immobilized enzymes	$42.3M	SEB, Industrifonden & 5 others	57/100
5th	Immobazyme 2019, Stellenbosch (South Africa), Series A	Developer of enzyme immobilisation technology	$2.9M	UTF, Fireball Capital & 2 others	51/100
6th	Genovis 1999, Lund (Sweden), Public	Develps enzymes for antibodies	-	Northislet, Hansa Biopharma	50/100
7th	Allozymes 2019, Singapore (Singapore), Series A	Developer of enzyme engineering platform for biosolutions across diverse industries	$20M	Seventure Partners, Xora Innovation & 8 others	48/100
8th	Twelve Bio 2019, Copenhagen (Denmark), Acquired	Developer of CRISPER technology based diagnostics and therapeutics	$2.57M	Arix Bioscience, BioInnovation Institute	45/100
9th	Nucleus Biologics 2016, San Diego (United States), Funding Raised	Cell culture solutions provider accelerating cell and gene therapy development	-	-	43/100
10th	New England Biolabs 1970, Ipswich (United Kingdom), Funding Raised	Molecular biology reagents company	-	National Science Foundation, NIH SBIR/STTR ... & 2 others	43/100